Dallah Healthcare Company announced that its board of directors has approved the resignation of the board member, Dr. Fahad bin Abdulaziz Al-Rabiah, from the membership of the board of directors and compensation and remuneration committee, effective from November 15, 2022 due to his personal reasons.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
168.6 SAR | +0.96% | +4.46% | -1.86% |
09:00am | Dallah Healthcare Posts Higher Q1 Net Profit, Revenue | MT |
Mar. 20 | Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.86% | 4.35B | |
-18.90% | 16.51B | |
+4.50% | 12.53B | |
+4.81% | 11.74B | |
+2.21% | 10.06B | |
+29.69% | 8.71B | |
-3.46% | 7.57B | |
+18.60% | 7.14B | |
+5.46% | 6.68B | |
-7.07% | 4.17B |
- Stock Market
- Equities
- 4004 Stock
- News Dallah Healthcare Company
- Dallah Healthcare Company Approves Resignation of Fahad Bin Abdulaziz Al-Rabiah as Board of Directors and Compensation and Remuneration Committee